Abstract
Acute asthma is one of the most common conditions resulting in emergency room visits and hospitalizations in children. The direct economic burden of acute asthma is estimated to be 340 million dollars, and this cost does not take into account the cost of physician services, or the indirect cost of caretaker days lost from work and childhood school absences [1].
Author for correspondence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weiss KB, Gergen PJ, Hodgson TA (1992) An economic evaluation of asthma in the United States. N Engl J Med 326: 862–866.
National Asthma Education Program Expert Panel Report (1991) Guidelines for the Diagnosis and Management of Asthma. NIH publication no 91–3042, August.
NHLBI/WHO Workshop Report (1995) Global Initiatives for Asthma: Global Strategy for Asthma Management and Prevention. NIH publication no 95–3659, January.
British Thoracic Society (1993) Guidelines on the management of asthma. Thorax 48: S1–S24.
Ben-Zvi Z, Lam C, Hoffman J, Teets-Grimm K, Kaftan M (1982) An evaluation of the initial treatment of acute asthma. Pediatrics 70: 348–353.
Becker AB, Nelson NA, Simons FER (1983) Inhaled salbutamol (albuterol) vs. injected epinephrine in the treatment of acute asthma in children. J Pediatr 102: 465–469.
Robertson CF, Smith F, Beck R, Levison H (1985) Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 106: 672–674.
Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, Tan YK, Levison H, Soldin SJ (1989) High versus low dose, frequently administered nebulized albuterol in children with severe, acute asthma. Pediatrics 83: 513–518.
Moler FW, Hurwitz ME, Custer JR (1988) Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 81: 1101–1109.
Papo MC, Frank J, Thompson AE (1993) A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 21: 1479–1486.
Lowenthal D, Kaftan M (1992) Facemasks vs mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 14: 192–196.
Chou KJ, Cunningham SJ, Crain EF (1995) Metered-dose inhalers with spacers vs. nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 149: 201–205.
Parry WH, Martorano F, Cotton EK (1976) Management of life-threatening asthma with intravenous isoproterenol infusions. Am JDis Child 130: 39–42.
Williams S, Seaton A (1977) Intravenous or inhaled salbutamol in severe acute asthma? Thorax 32: 555–558.
Herman JJ, Noah ZL, Moody RR (1983) Use of intravenous isoproterenol in status asthmaticus in children.Crit Care Med 11: 716–720.
Wood DW, Downes JJ, Scheinkoph H, Leaks HL (1972) Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. JAllergy Clin Immunоl 50: 75–81.
Bohn D, Kalloghlian A, Jenkins J, Edmonds J, Barker G (1984) Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 121: 892–896.
Kurland G, Williams J, Lewiston NJ (1979) Fatal myocardial toxicity during continuous infusion of intravenous isoproterenol therapy in asthma. J Allergy Clin Immunol 63: 407–411.
Maguire JF, Geha RS, Umetsu DT (1986) Myocardial specific creatine phsophokinase isoenzyme elevation in children with asthma treated with intravenous isoproterenol. J Allergy Clin Immunol 78: 631–636.
Maguire JF, O’Rourke PP, Colan SD, Geha RS, Crone R (1991) Cardiotoxicity during treatment of severe childhood asthma. Pediatrics 88: 1180–1186.
Matson JR, Loughlin GM, Strunk RC (1978) Myocardial ischemia complicating the use of isoproterenol in asthmatic children. J Pediatr 92: 776–778.
Tashkin DP, Jenne JW (1985) Alpha-and beta-adrenergic agents (1985) In: Weiss EB, Segal MS, Stein MS (eds). Bronchial Asthma Boston/Toronto: Little, Brown, 611–617.
Fuglsang G, Pedersen S, Borgstrom L (1989) Dose-response relationships of intravenously administered terbutaline in children with asthma. J Pediatr 114: 315–320.
Lawford P, Jones BJM, Milledge JS (1978) Comparison of intravenous and nebulized salbutamol in initial treatment of severe asthma Br Med J 1: 84.
Pierce RJ, Payne CR, Williams SJ, Denison DM, Clark TJH (1981) Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest 79: 506–511.
Swedish Society of Chest Medicine (1990) High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Eur Respir J 3: 163–170.
Van Renteghem D, Lamont H, Elinck W, Pauwels R, Van Der Straeten M (1987) Intravenous versus nebulized terbutaline in patients with acute severe asthma: a double-blind randomized study. Ann Allergy 59: 313–316.
Williams SJ, Winner SJ, Clark TJH (1981) Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax 36: 629–631.
Moore J, Claud D, Driscoll D, Kaufman C, RolsonA (1992) Intravenous terbutaline control of severe pediatric asthma. Am Rev Respir Dis 145: A740.
Hultquist C, Lindberg C, Nyberg L, Kjellman B, Wettrell G (1989) Pharmacokinetics of intravenous terbutaline in asthmatic children. Dev Pharmacol Ther 13: 11–20.
Nogrady SG, Hartley JPR, Seaton A (1977) Metabolic effects of intravenous salbutamol in the course of acute severe asthma. Thorax 32: 559–562.
Dietrich KA, Conrad SA, Romero MD (1991) Creatinine kinase (CK) isoenzymes in pediatric status asthmaticus treated with intravenous terbutaline. Am Rev Respir Dis 19(14):s39.
Laaban JP, Iung B, Chauvet JP, Psychoyos I, Proteau J, Rochemaure J (1988) Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus. Chest 94: 496–502.
Haffner CA, Hughes B, Kendall MJ, Holder R (1992) Pilot study to compare the bronchodilator and metabolic responses to terbutaline infusion in seven asthmatic subjects - are they correlated? J Clin Pharm Therapeutics 17: 229–232.
Clifton GD, Hunt BA, Patel RC, Burki NK (1990) Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses. Am Rev Respir Dis 141: 575–579.
Clausen T, Flatman JA (1977) The effect of catecholarnines on Na-K transport and membrane potential in rat soleus muscle. JPhysiol (Lond) 270: 383–414.
Smith SR, Kendall MJ (1986) Potentiation of the adverse effects of intravenous terbutaline by oral theophylline. Br J Clin Pharmaco121: 451–453.
O’Connel MB, Iber C (1990) Continuous terbutaline infusions for adult patients with status asthmaticus. Ann Allergy 64: 213–218.
Brady HR, Ryan F, Cunningham J, Tormey W, Ryan MP, O’Neill S (1989) Hypophosphatemia complicating bronchodilator therapy for acute severe asthma. Arch Intern Med 149: 2367–2368.
Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadden ER Jr. (1980) Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 122: 365–371.
Rossing TH, Fanta CH, McFadden ER Jr. (1981) A controlled trial of the use of single versus combined-drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis 123: 190–194.
Siegel D, Sheppard D, Gelb A, Weinberg PF (1985) Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis 132: 283–286.
DiGiulio GA, Keresmar CM, Krug SE, Alpert SE, Marx CM (1993) Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. JPediatr 122: 464–469.
Needleman JP, Kaifer MC, Nold JT, Shuster PE, Redding MM, Gladstein J (1995) Theophylline does not shorten hospital stay for children admitted for asthma. Arch Pediatr Adolesc Med 149: 206–209.
Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ (1994) Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 93: 205–210.
Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L (1993) Efficacy of intravenously administered theophylline in children hospitalized with severe asthma. JPediatr 122: 470–476.
Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ (1996) Theophylline: potential antiinflanunatory effects in nocturnal asthma. JAllergy Clin Immunol 97: 1242–1246.
Aubier M (1987) Effect of theophylline on diaphragmatic muscle function. Chest 92: 27s-31 s.
Medical Research Council (1956) Controlled trial of cortisone acetate in status asthmaticus. Lancet 2: 803–806.
Fanta CH, Rossing TH, McFadden ER Jr. (1983) Glucocorticoids in acute asthma: a controlled trial. Am J Med 74: 845–851.
Feil SB, Swartz NA, Glanz K, Francis ME (1983) Efficacy of short-term corticosteroid therapy in out-patient treatment of acute bronchial asthma. Am JMed 75: 259–262.
Harris JB, Weinberger M, Nassif E, Smith A, Milavetz G, Stillerman A (1987) Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. JPediatr 110: 627–633.
Chapman KR, Verbeek PR, White JG, Rebuck AS (1991) Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med 324: 788–794.
Stein LM, Cole RP (1990) Early administration of corticosteroids in emergency treatment of acute asthma. Ann Intern Med 112: 822–827.
Morell R, Orriols R, de Garcia J, Pujol A (1992) Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax 47: 588–591.
Kelly HW, Murphy S (1991) Corticosteroids for acute, severe asthma. DICPAnn Pharmacother 25: 72–79.
Rowe BH, Keller JL, Oxman AD (1992) Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am JEmerg Med 10: 301–310.
Storr J, Barrell E, Barry W, Lenney W, Hatcher G (1987) Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1: 879–881.
Younger RE, Gerber PS, Herrod HG, Cohen RM, Crawford LV (1987) Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics 80: 225–230.
Scarfone RJ, Fuchs SM, Nager AL, Shane SA (1993) Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 92: 513–518.
Connett GJ, Warde C, Wooler E, Lenney W (1994) Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child 70: 170–173.
Ratto DM, Alfaro C, Sipsey J, Glovshy MM, Sharma OP (1988) Are intravenous corticosteroids required in status asthmaticus. J Am MedAssoc 260: 527–529.
McFadden ER Jr. (1993) Dosage of corticosteroids in asthma. Am Rev Respir Dis 147: 1306–1310.
Anon (1992) Steroids in acute severe asthma. Lancet 340: 1384–1385.
Barnes PJ, Basbaum CB, Nadel JA (1983) Autoradiographic localization of autonomic receptors in airway smooth muscle. Am Rev Respir Dis 127: 758–762.
Gross NJ (1988) Ipratropium bromide. N Engl J Med 319: 486–494.
Beck R, Robertson C, Galdes-Sebaldt M, Levison H (1985) Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. JPediatr 107: 605–608.
Watson WTA, Becker AB, Simons FER (1988) Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J Allergy Clin Immunol 82: 1012–1018.
Schuh S, Johnson DW, Callahan S, Canny G, Levison H (1995) Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 126: 639–645.
Levine BS, Coburn JW (1984) Magnesium, the mimic/antagonist of calcium. N Engl J Med 310: 1253–1255.
Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S (1994) Dietary magnesium, lung function, wheezing and airway hyperreactivity in a random adult population sample. Lancet 344: 357–362.
Haury VG (1938) The bronchodilator action of magnesium and its antagonistic action (dilator action) against pilocarpine, histamine and barium chloride. JPharm Exp Ther 64: 58–64.
Skorodin MS, Freedbeck RC, Yetter B, Nelson JE, Van de Graaff WB, Walsh JM (1994) Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 105: 701–705.
Rolla G, Bucca C, Brossino L, Colagrande P (1994) Effect of intravenous magnesium infusion on salbutamol-induced bronchodilatation in patients with asthma. Mag Res 7: 129–133.
Altura BM, Altura BT, Carella A (1983) Magnesium deficiency induced spasms of umbilical vessels: Relation to preeclampsia, hypertension, growth retardation. Science 221: 376–378.
Bois P (1963) Effect of magnesium deficiency on mast cells and urinary histamine in rats. Br J Ехp Path 44: 151–155.
del Catillo J, Engbaek L (1954) The nature of the neuromuscular block produced by magnesium. J Physiol 124: 370–384.
Haury VG (1940) Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate. J Lab Clin Med 26: 340–344.
DeValk HW, Kok PTM, Struyvenberg A, Van Rijn HJM, Haalbom JRE, Kreukniet J, Lammers JWJ (1993) Extracellular and intracellular magnesium concentrations in asthmatic patients. Eur Respir J 6: 1122–1125.
Skobeloff EM, Spivey WH, McNamara RM, Greenspon L (1989) Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. J Am Med Assoc 262: 1210–1213.
Green SM, Rothrock SG (1992) Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med 21: 260–265.
Tiffany BR, Berk WR, Keir I, White SR (1993) Magnesium bolus or infusion fail to improve expiratory flow in acute asthma exacerbations. Chest 104: 831–834.
Ciarralo L, Sauer AH, Shannon MW (1996) Intravenous magnesium in moderate to severe pediatric asthma: results of a randomized placebo-controlled trial. JPediatr 129: 809–814.
Fesmire FN (1993) Intravenous magnesium for acute asthma (correspondence). Ann Emerg Med 22: 616–617.
Schiermeyer RP, Finkelstein JA (1994) Rapid infusion of magnesium sulfate obviates the need for intubation in status asthmaticus. Am J Emerg Med 12: 164–166.
Noppen M, Vanmaele L, Impens N, Schandevyl W (1990) Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 97: 373–376.
Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T (1987) Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAm Med Assoc 257: 1076–1078.
Chande V, Skoner D (1992) A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients. Ann Emerg Med 21: 1111–1115.
Clark MC, Wright GD, Falk JL, Malone L, Robelli JP (1991) Aerosolized magnesium sulfate as acute therapy for pediatric asthma (abstract). Ann Emerg Med 20: 448.
McLean RM (1994) Magnesium and its therapeutic uses: a review. Am J Med 96: 63–76.
Bodenhamer J, Bergstrom R, Brown D, Gabow P, Marx JA, Lowenstein SR (1992) Frequently nebulized beta-agonists for asthma: effects on serum electrolytes. Ann Emerg Med 21(11): 1337–1342.
Rolla G, Bucca C (1989) Hypomagnesemia and bronchial hyperreactivity. A case report. Allergy 44: 519–521.
Roy TM, Pruitt VL, Garner PA, Heine MF (1992) The potential role of anesthesia in status asthmaticus. J Asthma 29(2): 73–77.
Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P (1985) Pulmonary and systemic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 62: 287–293.
Morray JP, Lynn AM, Stamm SJ, Herndon PS, Kawabori I, Stevenson JG (1984) Hero-dynamic effects of ketamine in children with congenital heart disease. Anesth Analg 63: 895–899.
Rock MJ, Reyes De La Rocca S, L’Hоmmedieи CS, Truemper E (1986) Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 14: 514–516.
Strube PJ, Hallam PL (1986) Ketamine by continuous infusion in status asthmaticus. Anaesthesia 41: 1017–1019.
Wanna HT, Gergis SD (1978) Procaine, lidocaine and ketamine inhibit histamine-induced contracture of guinea pig tracheal muscle in vitro. Anesth Analg 57: 25–27.
Cabanas A, Souhrada FL, Aldete JA (1980) Effects of ketamine and halothane on normal and asthmatic smooth muscle of the airway of guinea pigs. Can Anaesth Soc J 27: 47–51.
L’Hommedieu CS, Arens JJ (1987) The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 16: 568–571.
Coyle JP, Cullen DJ (1988) Anesthetics and critical care. In: Chernow B (ed.) The Pharmacologic Approach to the Critically Ill Patient, second edition, Baltimore, Williams and Wilkins, 241–253.
Schwartz SH (1984) Treatment of status asthmaticus with halothane. J Am MedAssoc 251: 2688–2689.
Hickey RF, Graf PD, Nadel JA, Larson CP Jr. (1969) The effects of halothane and cyclopropane on total pulmonary resistance in the dog. Anesthesiology 31: 334–343.
DeNicola LR, Aboudan K (1990) Resistant status asthmaticus in children. J Florida Med Assoc 77: 809–813.
Saulnier FF, Durocher AV, Deturck RA, Lefebvre MC, Wattel FE (1990) Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 16: 104–107.
Echeverria M, Gelb AW, Wexler HR, Ahmad D, Kenefick P (1986) Enflurane and halo-thane in status asthmaticus. Chest 89: 152–154.
Zink J, Sasyniuk BI, Dresel PE (1975) Halothane-epinephrine-induced cardiac arrhythmias and the role of heart rate. Anesthesiology 43: 548–555.
Otte RW, Fireman P (1991) Isoflurane anesthesia for the treatment of refractory status asthmaticus. Ann Allergy 66: 305–309.
Rosseel P, Lauwers LF, Baute L (1985) Halothane treatment in life-threatening asthma. Intensive Care Med 11: 241–246.
Takaori M, Loehning R (1965) Ventricular arrhythmias during halothane anaesthesia: effect of isoproterenol, aminophylline, and ephedrine. Can Anaesth Soc J 12: 275–280.
Joas TA, Stevens WC (1971) Comparison of the arrhythmic doses of epinephrine during florane, halothane, and fluroxane anesthesia in dogs. Anesthesiology 35: 48–53.
Revell S, Greenhalgh D, Absalom SR, Soni N (1988) Isoflurane in the treatment of asthma. Anaesthesia 43: 477–479.
Colaco CM, Crago RR, Weisbert A (1978) Halothane for status asthmaticus in the intensive care unit: a case report. Can Anaesth Soc J 25: 329–330.
Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL (1986) Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 14: 832–833.
Parnass SM; Feld JM, Chamerlin WH, Segil LJ (1987) Status asthmaticus treated with isoflurane and enflurane. Anest Analg 66: 193–195.
Johnston RG, Noseworthy TW, Friesen EG, Yule HA, Shustack A (1990) Isoflurane therapy for status asthmaticus in children and adults. Chest 97: 698–701.
O’Rourke PP, Crone RK (1982) Halothane in status asthmaticus. Crit Care Med 10: 341–343.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Basel AG
About this chapter
Cite this chapter
Kattan, M., Hojsak, J.M. (1997). Treatment of Acute Life-Threatening Asthma in Children. In: Wilmott, R.W. (eds) The Pediatric Lung. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8960-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8960-5_6
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9845-4
Online ISBN: 978-3-0348-8960-5
eBook Packages: Springer Book Archive